Tower Research Capital LLC (Trc) Palisade Bio, Inc. Transaction History

Tower Research Capital LLC (Trc)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.11 - $83.85 $1,329 - $1.01 Million	-12,084 Reduced 40.09%	18,059 $2,000
Q2 2022 Aug 15, 2022	BUY	$0.41 - $1.04 $10,235 - $25,963	24,965 Added 482.14%	30,143 $12,000
Q1 2022 May 12, 2022	BUY	$0.81 - $1.51 $31 - $58	39 Added 0.76%	5,178 $5,000
Q4 2021 Feb 14, 2022	BUY	$1.3 - $2.96 $6,680 - $15,211	5,139 New	5,139 $7,000
Q3 2021 Nov 15, 2021	SELL	$2.35 - $3.93 $2,136 - $3,572	-909 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.49 - $11.34 $3,172 - $10,308	909 New	909 $4,000

Ticker PALI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,240,200
Market Cap $122M
Description
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzym...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.